A Phase 1 Open Labeled Single Ascending Dose Followed by Multiple Ascending Dose Safety and Pharmacokinetic Study of HBI-002 Carbon Monoxide Oral Liquid Drug Product in Healthy Adult Volunteers. - ICH GCP - Clinical Trials Registry